JLens 500 Jewish Advocacy U.S. ETF (NYSEARCA:TOV – Get Free Report) was the recipient of a large increase in short interest in July. As of July 31st, there was short interest totaling 13,260 shares, an increase of 596.1% from the July 15th total of 1,905 shares. Based on an average daily volume of 2,556 shares, the days-to-cover ratio is currently 5.2 days. Currently, 0.2% of the company’s stock are sold short.
JLens 500 Jewish Advocacy U.S. ETF Stock Performance
Shares of TOV remained flat at $32.47 during trading on Wednesday. The company’s stock had a trading volume of 720 shares, compared to its average volume of 11,172. The business’s fifty day moving average price is $31.51 and its two-hundred day moving average price is $30.06. JLens 500 Jewish Advocacy U.S. ETF has a one year low of $26.52 and a one year high of $32.72. The company has a market cap of $272.75 million, a P/E ratio of 25.69 and a beta of 1.03.
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. acquired a new stake in shares of JLens 500 Jewish Advocacy U.S. ETF in the 3rd quarter valued at about $25,000. Bank of New York Mellon Corp grew its stake in JLens 500 Jewish Advocacy U.S. ETF by 66.7% in the first quarter. Bank of New York Mellon Corp now owns 71,189 shares of the company’s stock worth $1,946,000 after purchasing an additional 28,496 shares in the last quarter. Finally, Captrust Financial Advisors acquired a new position in JLens 500 Jewish Advocacy U.S. ETF in the second quarter worth about $6,038,000.
JLens 500 Jewish Advocacy U.S. ETF Company Profile
The JLens 500 Jewish Advocacy U.S. ETF (TOV) is an exchange-traded fund that is based on the JLens 500 Jewish Advocacy U.S. index. The fund tracks an index of large-cap US stocks while employing a methodology that seeks to align stock selection and weighting with Jewish value pillars. TOV was launched on Feb 26, 2025 and is issued by JLens.
See Also
- Five stocks we like better than JLens 500 Jewish Advocacy U.S. ETF
- Hims & Hers’ Revenue Beat Came With a Profitability Problem
- A Westinghouse IPO Could Reset the Nuclear Stock Conversation
- Fastly’s Q2 Rally Shows Investors Are Buying the Edge AI Turnaround
- Paramount’s 30-Film Promise Puts AMC Back in the Box Office Conversation
Receive News & Ratings for JLens 500 Jewish Advocacy U.S. ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JLens 500 Jewish Advocacy U.S. ETF and related companies with MarketBeat.com's FREE daily email newsletter.
